A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum-sensitive ovarian cancer (OC): CALYPSO study of the Gynecologic Cancer Intergroup (GCIG)
2009 ◽
Vol 27
(15_suppl)
◽
pp. LBA5509-LBA5509
Keyword(s):
LBA5509 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. No significant financial relationships to disclose.
2009 ◽
Vol 27
(18S)
◽
pp. LBA5509-LBA5509
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 5012-5012
◽
2009 ◽
Vol 7
(3)
◽
pp. 11
◽
Keyword(s):
2009 ◽
Vol 27
(15_suppl)
◽
pp. LBA5510-LBA5510
Keyword(s):
2009 ◽
Vol 27
(18_suppl)
◽
pp. LBA5509-LBA5509
◽
2015 ◽
Vol 51
(3)
◽
pp. 352-358
◽
2009 ◽
Vol 27
(15_suppl)
◽
pp. LBA5508-LBA5508
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA5002-LBA5002
◽
Keyword(s):